Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 272

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

Pahor, Marco, Guralnik, Jack M., Corti, Maria‐Chiara, Foley, Daniel J., Carbonin, Pierugo, Havlik, Richard J.·1995·Journal of the American Geriatrics Society

Abstract

OBJECTIVE: To determine whether older persons with hypertension who use specific calcium antagonists and ACE inhibitors have a different risk of mortality than those using β‐blockers. DESIGN: A prospective cohort study continuing from 1988 through 1992. SETTING: Three communities of the Established Populations for Epidemiologic Studies of the Elderly. PARTICIPANTS: Hypertensive participants aged s 71 years (n = 906) who had no evidence of congestive heart failure and who were using either /3‐blockers (n = 515), verapamil (n = 77), diltiazem (n = 92), nifedipine (n = 74), or ACE inhibitors (n = 148). Nifedipine was of the short acting variety. MEASUREMENTS: The main outcome measure was all‐cause mortality. Age, gender, smoking, HDL‐cholesterol, blood pressure, intake of digoxin and diuretics, physical disability, self‐perceived health, and comorbid conditions were examined as confounders. RESULTS: During 3538 person‐years of follow‐up, 188 participants died (53 deaths per 1000 person‐years). Compared with j3‐blockers, after adjusting for age, gender, comorbid conditions and other health‐related factors, the relative risks (95% confidence interval) for mortality associated with use of verapamil, diltiazem, nifedipine, and ACE inhibitors were 0.8 (0.4‐1.4), 1.3 (0.8‐2.1), 1.7 (1.1–2.7), and 0.9 (0.6‐1.4), respectively. The results were unchanged after excluding participants with other potential contraindications to /3‐blockers and after stratifying on coronary heart disease and use of diuretics. Higher doses of nifedipine were associated with higher mortality. CONCLUSION: Compared with /3‐blockers, use of short acting nifedipine was associated with decreased survival in older hypertensive persons. However, selective factors influencing the use of specific drugs in higher risk patients could not be completely discounted, and final conclusions will depend on clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.1995.tb07393.x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 272

Metadata

Authors
Pahor, M., Guralnik, J. M., Corti, M., Foley, D. J., Carbonin, P., & Havlik, R. J.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
1995-11
Volume
43
Issue
11
Pages
1191-1197
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2058645062
Cited by
272
References
35
FWCI
34.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐Term Survival and Use of Antihypertensive Medications in Older Persons. https://app.cochat.ai/papers/10.1111/j.1532-5415.1995.tb07393.x
The paper
Pahor, M., Guralnik, J. M., Corti, M., Foley, D. J., Carbonin, P., & Havlik, R. J. (1995). Long‐Term Survival and Use of Antihypertensive Medications in Older Persons. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1995.tb07393.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.